Results 61 to 70 of about 790 (114)
International Journal of Nanomedicine, 2015 Dandan Liu,1 Hao Pan,2 Fengwei He,1 Xiaoyu Wang,3 Jinyu Li,3 Xinggang Yang,3 Weisan Pan31Department of Pharmaceutical Engineering, School of Biomedical and Chemical Engineering, Liaoning Institute of Science and Technology, Benxi, People’s Republic
Liu DD +6 more
doaj
Cardiovascular Diabetology, 2011 Background Carvedilol has been shown to be superior to metoprolol tartrate to improve clinical outcomes in patients with heart failure (HF), yet the mechanisms responsible for these differences remain unclear.
Køber Lars +8 more
doaj +1 more source
Nano and Microparticulate Chitosan Based System for Formulation of Carvedilol Rapid Melt Tablet
Advanced Pharmaceutical Bulletin, 2015 Purpose: In the present study rapid melt tablets (RMT’s) of carvedilol were prepared by using ionotropic-gelated chitosan nanoparticles using a spray-drying method.
Ravindra Patil +2 more
doaj +1 more source
Carvedilol and bisoprolol effectiveness in patients with myocardial infarction and heart failure
Кардиоваскулярная терапия и профилактика, 2008 Aim. To assess carvedilol and bisoprolol effects on clinical symptoms, hemodynamics and morpho-functional heart characteristics in patients with myocardial infarction (MI) and chronic heart failure (CHF).Material and methods.
A. I. Chesnikova +3 more
doaj
Drugs in ContextBackground: Carvedilol has shown greater potency than propranolol as a β-blocker in managing cardiac conditions. However, its efficacy in reducing portal hypertension (PHTN) in patients with cirrhosis remains unclear.
Siddheesh Rajpurohit +4 more
doaj +1 more source
Carvedilol sensitizes chemotherapy by targeting STING to boost anti-tumor immunity
Cell ReportsSummary: The stimulator of interferon genes (STING)-mediated type I interferon (IFN) response is critical for mounting anti-tumor immunity and sensitizing chemotherapy by remodeling the tumor immune microenvironment.
Yifang Dang +14 more
doaj +1 more source
Vascular Health and Risk Management, 2007 Britt Kveiborg, Atheline Major-Petersen, Buris Christiansen, Christian Torp-PedersenDepartment of Cardiology, Bispebjerg University Hospital, Copenhagen, DenmarkAbstract: Beta-blockers have been shown to improve survival in patients with chronic heart ...
Britt Kveiborg +3 more
doaj
Arquivos Brasileiros de Cardiologia, 2010 FUNDAMENTO: Grandes estudos clínicos empregando os betabloqueadores carvedilol, metoprolol, bisoprolol e nebivolol, demonstraram melhora da sobrevida e dos sintomas em pacientes com insuficiência cardíaca.
Fabiana Marques +6 more
doaj